Fell pony syndrome: Characterization of developmental hematopoiesis failure and associated gene expression profiles

Clinical and Vaccine Immunology

Volumn 19, Issue 7, 2012, Pages 1054-1064

  Tallmadge, Rebecca L ^a   Stokol, Tracy ^a   Gould Earley, Mary Jean ^b   Earley, Ed ^b   Secor, Erica J ^a   Matychak, Mary Beth ^a   Felippe, M Julia B ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Laurel Highland Farm and Equine Services LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; IMMUNOGLOBULIN; PROTEIN MYB; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ANIMAL TISSUE; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; BLOOD CELL COUNT; BONE MARROW CELL; CELL HYPERPLASIA; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREB1 GENE; DNA SEQUENCE; EP300 GENE; FELL PONY SYNDROME; FOAL; GENE; GENE EXPRESSION PROFILING; GENE SEQUENCE; HEMATOCRIT; HEMATOPOIESIS; HORSE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MYB GENE; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PAX5 GENE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SPI1 GENE;

ANEMIA; ANIMALS; B-LYMPHOCYTES; BONE MARROW; GENE EXPRESSION PROFILING; HEMATOCRIT; HEMATOPOIESIS; HORSE DISEASES; HORSES; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE COUNT; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84863545533     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00237-12     Document Type: Article

References (77)

1. Back J, Dierich A, Bronn C, Kastner P, Chan S. 2004. PU.1 determines the self-renewal capacity of erythroid progenitor cells. Blood 103:3615-3623. (Pubitemid 38596273)
2. Bedell MA, Cleveland LS, O'Sullivan TN, Copeland NG, Jenkins NA. 1996. Deletion and interallelic complementation analysis of Steel mutant mice. Genetics 142:935-944. (Pubitemid 26162536)
3. Bell SC, Savidge C, Taylor P, Knottenbelt DC, Carter SD. 2001. An immunodeficiency in Fell ponies: a preliminary study into cellular responses. Equine Vet. J. 33:687-692. (Pubitemid 33640029)
4. Berry GT, et al. 2003. Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J. Biol. Chem. 278:18297-18302. (Pubitemid 36799449)
5. Bordon A, et al. 2008. Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development. PLoS One 3:e4007. doi:10.1371/journal.pone.0004007.
6. Butler CM, Westermann CM, Koeman JP, Sloet van Oldruitenborgh-Oosterbaan MM. 2006. The Fell pony immunodeficiency syndrome also occurs in the Netherlands: a review and six cases. Tijdschr. Diergeneeskd. 131:114-118. (Pubitemid 43324419)
7. Chau JF, Lee MK, Law JW, Chung SK, Chung SS. 2005. Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J. 19:1887-1889. (Pubitemid 41598784)
8. Cioc AM, Wagner JE, MacMillan ML, DeFor T, Hirsch B. 2010. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics. Am. J. Clin. Pathol. 133:92-100.
9. Corcoran LM, Koentgen F, Dietrich W, Veale M, Humbert PO. 2004. All known in vivo functions of the Oct-2 transcription factor require the C-terminal protein domain. J. Immunol. 172:2962-2969. (Pubitemid 38263683)
10. Dai Z, et al. 2011. Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation. J. Bone Miner. Res. 26:582-590.
11. Dolence JJ, Gwin K, Frank E, Medina KL. 2011. Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors. Eur. J. Immunol. 41:324-334.
12. Douagi I, Vieira P, Cumano A. 2002. Lymphocyte commitment during embryonic development, in the mouse. Semin. Immunol. 14:361-369.
13. Emambokus N, et al. 2003. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J. 22:4478-4488. (Pubitemid 37087201)
14. Engel P, et al. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39-50.
15. Eynon EE, Kuida K, Flavell RA. 1996. Disruption of cytokine signaling in lymphoid development: unique contributions of the common cytokine gamma chain and the Jak3 kinase. J. Interferon Cytokine Res. 16:677-684. (Pubitemid 26330413)
16. Fitzsimmons D, et al. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198-2211. (Pubitemid 26303875)
17. Flaminio MJ, et al. 2007. The effect of CpG-ODN on antigen presenting cells of the foal. J. Immune Based Ther. Vaccines 5:1.
18. Flaminio MJ, LaCombe V, Kohn CW, Antczak DF. 2002. Common variable immunodeficiency in a horse. J. Am. Vet. Med. Assoc. 221:1296-1302, 1267.
19. Flaminio MJ, et al. 2000. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet. Immunol. Immunopathol. 73:267-285. (Pubitemid 30125467)
20. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. 1995. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 171:1090-1096.
21. Fox-Clipsham L, et al. 2009. Immunodeficiency/anaemia syndrome in a Dales pony. Vet. Rec. 165:289-290.
22. Fox-Clipsham LY, et al. 2011. Identification of a mutation associated with fatal foal immunodeficiency syndrome in the Fell and Dales pony. PLoS Genet. 7:e1002133. doi:10.1371/journal.pgen.1002133.
23. Gardner RB, Hart KA, Stokol T, Divers TJ, Flaminio MJ. 2006. Fell Pony syndrome in a pony in North America. J. Vet. Intern. Med. 20:198-203. (Pubitemid 43219392)
24. Hoelbl A, et al. 2006. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 107:4898-4906. (Pubitemid 43882643)
25. Huntington ND, et al. 2006. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat. Immunol. 7:190-198. (Pubitemid 43135885)
26. Iolascon A, Russo R, Delaunay J. 2011. Congenital dyserythropoietic anemias. Curr. Opin. Hematol. 18:146-151.
27. Jalovecka M, et al. 2010. Activation of protective cell-mediated immune response in gastric mucosa during Cryptosporidium muris infection and re-infection in immunocompetent mice. Parasitol. Res. 106:1159-1166.
28. Jelinek F, Faldyna M, Jasurkova-Mikutova G. 2006. Severe combined immunodeficiency in a Fell pony foal. J. Vet. Med. A Physiol. Pathol. Clin. Med. 53:69-73.
29. Jung S, Rajewsky K, Radbruch A. 1993. Shutdown of class switch recombination by deletion of a switch region control element. Science 259:984-987. (Pubitemid 23080670)
30. Kasper LH, et al. 2002. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 419:738-743. (Pubitemid 35177961)
31. Kathiresan S, et al. 2009. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41:334-341.
32. Khan WN, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283-299.
33. Khan WN, et al. 1997. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int. Immunol. 9:395-405. (Pubitemid 27113264)
34. Kikuchi K, Kondo M. 2006. Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birth. Proc. Natl. Acad. Sci. U. S. A. 103:17852-17857. (Pubitemid 44852249)
35. Kikuchi K, Lai AY, Hsu CL, Kondo M. 2005. IL-7 receptor signaling is necessary for stage transition in adult B cell development through upregulation of EBF. J. Exp. Med. 201:1197-1203. (Pubitemid 40629064)
36. Kim HG, et al. 2004. The ETS family transcription factor PU.1 is necessary for the maintenance of fetal liver hematopoietic stem cells. Blood 104:3894-3900.
37. Kitamura D, Rajewsky K. 1992. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154-156.
38. Kydd J, et al. 1994. Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, UK, July 1991. Vet. Immunol. Immunopathol. 42:3-60.
39. Lavoie JP, Spensley MS, Smith BP, Mihalyi J. 1989. Absorption of bovine colostral immunoglobulins G and M in newborn foals. Am. J. Vet. Res. 50:1598-1603.
40. Lin H, Grosschedl R. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376:263-267.
41. Lipovsky K, Bennett LA, Chen J. 2003. B-cell deficiency and reduced B-cell reconstitution in hemoglobin-deficit mice. Exp. Hematol. 31:1230-1236. (Pubitemid 37510028)
42. Lluis-Ganella C, et al. 2010. Additive effect of multiple genetic variants on the risk of coronary artery disease. Rev. Esp. Cardiol. 63:925-933.
43. Lunn D, Holmes M, Duffus W. 1993. Equine T-lymphocyte MHC II expression: variation with age and subset. Vet. Immunol. Immunopathol. 35:225-238.
44. Lunn DP, et al. 1998. Report of the Second Equine Leucocyte Antigen Workshop, Squaw Valley, California, July 1995. Vet. Immunol. Immunopathol. 62:101-143. (Pubitemid 28222407)
45. Mackarehtschian K, et al. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147-161.
46. Marcos MA, et al. 1997. Antigenic phenotype and gene expression pattern of lymphohemopoietic progenitors during early mouse ontogeny. J. Immunol. 158:2627-2637. (Pubitemid 127470519)
47. McDonald V, Robinson HA, Kelly JP, Bancroft GJ. 1994. Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells. Infect. Immun. 62:2289-2294. (Pubitemid 24157055)
48. McKenna HJ, et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95:3489-3497. (Pubitemid 30428482)
49. McKercher SR, et al. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:5647-5658. (Pubitemid 26385624)
50. Meffre E, Nussenzweig MC. 2002. Deletion of immunoglobulin beta in developing B cells leads to cell death. Proc. Natl. Acad. Sci. U. S. A. 99:11334-11339. (Pubitemid 34920926)
51. Michaelson JS, Singh M, Birshtein BK. 1996. B cell lineage-specific activator protein (BSAP). A player at multiple stages of B cell development. J. Immunol. 156:2349-2351. (Pubitemid 26091554)
52. Nielsen PJ, Georgiev O, Lorenz B, Schaffner W. 1996. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26:3214-3218. (Pubitemid 26411533)
53. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17:2319-2333. (Pubitemid 28171916)
54. Nutt SL, Urbanek P, Rolink A, Busslinger M. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11:476-491. (Pubitemid 27097646)
55. Parrish CR, Carmichael LE, Antczak DF. 1982. Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch. Virol. 72:267-278.
56. Pelanda R, Braun U, Hobeika E, Nussenzweig MC, Reth M. 2002. B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta. J. Immunol. 169:865-872. (Pubitemid 34753443)
57. Richards AJ, Kelly DF, Knottenbelt DC, Cheeseman MT, Dixon JB. 2000. Anaemia, diarrhoea and opportunistic infections in Fell ponies. Equine Vet. J. 32:386-391.
58. Rodig SJ, et al. 1998. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93:373-383. (Pubitemid 28232082)
59. Sandberg ML, et al. 2005. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev. Cell 8:153-166. (Pubitemid 40197733)
60. Scholes SF, Holliman A, May PD, Holmes MA. 1998. A syndrome of anaemia, immunodeficiency and peripheral ganglionopathy in Fell pony foals. Vet. Rec. 142:128-134. (Pubitemid 128520259)
61. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-1577.
62. Sinkora M, Butler JE. 2009. The ontogeny of the porcine immune system. Dev. Comp. Immunol. 33:273-283.
63. Sinkora M, Sinkorova J, Butler JE. 2002. B cell development and VDJ rearrangement in the fetal pig. Vet. Immunol. Immunopathol. 87:341-346. (Pubitemid 34665259)
64. Smith CA, Woodruff LS, Kitchingman GR, Rooney CM. 1996. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J. Virol. 70:6733-6740. (Pubitemid 26307380)
65. Souberbielle BE, Russell WC. 1995. Human T cell proliferative response to polypeptides from adenovirus type 2. J. Infect. Dis. 172:1421-1422.
66. Tallmadge RL, et al. 2009. Expression of essential B cell genes and immunoglobulin isotypes suggests active development and gene recombination during equine gestation. Dev. Comp. Immunol. 33:1027-1038.
67. Thomas GW, Bell SC, Carter SD. 2005. Immunoglobulin and peripheral B-lymphocyte concentrations in Fell pony foal syndrome. Equine Vet. J. 37:48-52. (Pubitemid 40091056)
68. Thomas GW, et al. 2003. Aid to the antemortem diagnosis of Fell pony foal syndrome by the analysis of B lymphocytes. Vet. Rec. 152:618-621. (Pubitemid 36656795)
69. Tober J, McGrath KE, Palis J. 2008. Primitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb. Blood 111:2636-2639.
70. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901-912. (Pubitemid 24371980)
71. von Freeden-Jeffry U, et al. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-1526.
72. Wang VE, Schmidt T, Chen J, Sharp PA, Tantin D. 2004. Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol. Cell. Biol. 24:1022-1032. (Pubitemid 38112167)
73. Waskow C, Terszowski G, Costa C, Gassmann M, Rodewald HR. 2004. Rescue of lethal c-KitW/W mice by erythropoietin. Blood 104:1688-1695. (Pubitemid 39202275)
74. Yeh WC, et al. 1997. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715-725.
75. You-Ten KE, et al. 1997. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J. Exp. Med. 186:683-693. (Pubitemid 27381533)
76. Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. 2008. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 28:183-196.
77. Zhuang Y, Soriano P, Weintraub H. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-884. (Pubitemid 24371977)